Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus — Seattle, Washington

Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus is a clinical research site located in Seattle, Washington, United States 98122.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer.

Sponsors: Carrick Therapeutics Limited.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus?

Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus conducted?

Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus has 1 clinical trials on record. Their work covers Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer.

Is Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus accredited by Crixeo Health?

Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 32 - Swedish Medical Center, Swedish Cancer Institute (SCI),Cherry Hill Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.